<DOC>
	<DOCNO>NCT01254604</DOCNO>
	<brief_summary>This study test hypothesis preservative-free tafluprost ( MK-2452 ) non-inferior preservative-free timolol maleate respect diurnal intraocular pressure ( IOP ) change baseline 4 week therapy participant open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Preservative-Free Tafluprost ( MK-2452 ) Treatment Open-Angle Glaucoma Ocular Hypertension ( MK-2452-002 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Participant diagnose primary openangle glaucoma , pigmentary glaucoma , capsular glaucoma/pseudoexfoliation , ocular hypertension Has use ocular hypotensive medication stable treatment regimen least 30 day prior screen , treatmentnaive ( never use use ocular hypotensive medication last 4 week prior screen ) Able discontinue topical and/or systemic ocular hypotensive medication washout period ( 4 week prestudy ) Bestcorrected early treatment diabetic retinopathy study ( ETDRS ) visual acuity 20/80 good eye Willing able avoid wear contact lens 4 week prior dose study medication 24 hour final dose Willing able selfadminister able person available daily basis assist administration study medication Participant reproductive potential must agree remain abstinent ( unless abstinence locally acceptable method contraception ) use highly effective method birth control ( hormonal contraceptive , intrauterine device , diaphragm , condom vasectomy ) within project duration study Able refrigerate study drug home . Mean IOP &gt; 36 mmHg either eye screening Unable use study medication affect eye ( ) History inflammatory ocular surface disease history anterior posterior uveitis either eye within 6 month prior screen History retinal detachment , proliferative diabetic retinopathy , progressive retinal disease Significant visual field loss evidence progressive visual loss within last year Intraocular surgery either eye last 4 month Any glaucoma surgery , refractive surgery , penetrate keratoplasty either eye Currently two antiglaucoma medication ( except Cosoptâ„¢ generic formulation ) Previously use tafluprost History cardiovascular disorder within 6 month screen History bronchial asthma , wheeze , chronic obstructive pulmonary disease ( COPD ) pulmonary disease , abnormal chest xray , current active pneumonia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Tafluprost</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Timolol</keyword>
	<keyword>Eye Disorder</keyword>
	<keyword>Preservative-Free</keyword>
	<keyword>Prostaglandin Analogue</keyword>
</DOC>